Novo Nordisk (NVO) Technical (Analysis) Reports Novo Nordisk ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Novo Nordisk (NVO)
Technical Analysis Report for USA stock NVO Novo Nordisk. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NVO Novo Nordisk then click here. or read Experts views on Novo Nordisk or Forecast & share price targets of Novo Nordisk
Novo Nordisk Opened at 46.10 and Closed at: 47.67, which is 9.08% of previous session's close. It moved within a range of 44.00 and 47.74
The session was a Bullish session with an average volume of 26977371, which is -98.97% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- There is some positive change in the mid term trend, but its too soon to jump onto conclusions.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
A Dead cross was found 3 days back on short term averages
A Dead cross was found 2 days back on long term averages
A Golden cross was found 6 days back on long term averages
Support for tomorrow is 45.84 and resistance for tomorrow is 49.58
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 45.2, 42.73 resistance for tomorrow's hourly charts is 48.94, 50.21
10 Day SMA for Novo Nordisk (NVO) is 55.34 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Novo Nordisk (NVO) is 57.73 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Novo Nordisk (NVO) is 53.21 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 53.36 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Novo Nordisk is 58.57 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Novo Nordisk is at 57.73 and 200 DMA is at 58.57, while 50 DMA and 100 DMA are at 53.21 and 53.36 respectively
Novo Nordisk (NVO) moving average of 20 SMA is at 57.73 and 20 EMA is at 54.91
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 47.67 | 57.73 | 54.91 |
| 05 Thu Feb | 43.34 | 58.21 | 55.67 |
| 04 Wed Feb | 47.19 | 58.88 | 56.97 |
| 03 Tue Feb | 50.31 | 59.33 | 58 |
| 02 Mon Feb | 58.97 | 59.57 | 58.81 |
| 30 Fri Jan | 59.43 | 59.24 | 58.79 |
Novo Nordisk (NVO) moving average of 50 SMA is at 53.21 and 50 EMA is at 54.42
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 47.67 | 53.21 | 54.42 |
| 05 Thu Feb | 43.34 | 53.16 | 54.7 |
| 04 Wed Feb | 47.19 | 53.24 | 55.16 |
| 03 Tue Feb | 50.31 | 53.25 | 55.48 |
| 02 Mon Feb | 58.97 | 53.23 | 55.69 |
| 30 Fri Jan | 59.43 | 53 | 55.56 |
Novo Nordisk (NVO) moving average of 100 SMA is at 53.36 and 100 EMA is at 55.06
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 47.67 | 53.36 | 55.06 |
| 05 Thu Feb | 43.34 | 53.42 | 55.21 |
| 04 Wed Feb | 47.19 | 53.53 | 55.45 |
| 03 Tue Feb | 50.31 | 53.6 | 55.62 |
| 02 Mon Feb | 58.97 | 53.65 | 55.73 |
| 30 Fri Jan | 59.43 | 53.62 | 55.66 |
Novo Nordisk (NVO) moving average of 200 SMA is at 58.57 and 200 EMA is at 62.58
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 47.67 | 58.57 | 62.58 |
| 05 Thu Feb | 43.34 | 58.64 | 62.73 |
| 04 Wed Feb | 47.19 | 58.74 | 62.93 |
| 03 Tue Feb | 50.31 | 58.82 | 63.09 |
| 02 Mon Feb | 58.97 | 58.89 | 63.22 |
| 30 Fri Jan | 59.43 | 58.93 | 63.26 |
Encompass Health has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Encompass Health, about 21.35% more returns!
Cvs Health has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Cvs Health, about 16.48% more returns!
Biohaven Pharmaceutical has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Biohaven Pharmaceutical, about 23.37% more returns!
Xeris Pharmaceuticals has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 7.36% more returns!
Spero Therapeutics has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Spero Therapeutics, about 13.86% more returns!
Pulmatrix Inc has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Pulmatrix Inc, about 24.04% more returns!
Microbot Medical has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Microbot Medical, about 3.72% more returns!
Lemaitre Vascular has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 21.81% more returns!
Lakeland Industries has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Lakeland Industries, about 27.75% more returns!
Iradimed Corporation has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Iradimed Corporation, about 15.95% more returns!
Novo Nordisk has performed better than Hoth Therapeutics in short term. Holding Novo Nordisk could be a better choice for now!
Novo Nordisk has performed better than Galmed Pharmaceuticals in short term. Holding Novo Nordisk could be a better choice for now!
Fate Therapeutics has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Fate Therapeutics, about 27.53% more returns!
Citius Pharmaceuticals has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Citius Pharmaceuticals, about 4.35% more returns!
Corcept Therapeutics has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 27.9% more returns!
Coherus Biosciences has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Coherus Biosciences, about 44.84% more returns!
Avadel Pharmaceuticals has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Avadel Pharmaceuticals, about 19.84% more returns!
Anixa Biosciences has performed better than Novo Nordisk in short term. You could have earned much better returns by investing in Anixa Biosciences, about 6.53% more returns!
Novo Nordisk Technical analysis of indicators
Price action analysis of Novo Nordisk (NVO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Novo Nordisk stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Novo Nordisk in short term and the sell signal is strong.
Novo Nordisk Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Novo Nordisk in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Novo Nordisk is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 51 and Novo Nordisk NVO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Novo Nordisk NVO stock. Volume based technical analysis of Novo Nordisk NVO stock is negative.
Novo Nordisk Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NVO Novo Nordisk These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NVO Experts View which covers a lot of information including buying and selling signals
NVO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Novo Nordisk or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Novo Nordisk (NVO) Technical (Analysis) Reports Novo Nordisk ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


